Physician

Jeffrey Todd Landis, M.D.

According to 2025 Medicare claims, Jeffrey Landis, M.D. (NPI: 1528155439) practices rheumatology in the Baltimore-Columbia-Towson, MD market, with the plurality of this provider's patient population coming from Baltimore, MD. This provider's primary affiliated billing organization is NASSERI CLINIC OF ARTHRITIC & RHEUMATIC DISEASES LLC (NPI: 1821286766; TIN: 200970121) and primary practice location at 21237-4325.

Landis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 680 traditional Medicare patients, billed 226,442 HCPCS/CPT codes, and received $3,227,172 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,940 prescription claims across 511 beneficiaries totaling $4,463,642 in drug costs, led by Humira(Cf) Pen (Adalimumab). DME data shows 14 claims. Open Payments data shows 51 records totaling $1,066. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $419,010 to $3,227,172. Similarly, Part D prescription costs have risen steadily, from $1,018,246 to $4,463,642. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $0 to $867.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.6M$3.2M2015 Medicare payment: $419,010 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $513,242 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $659,792 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,347,476 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,955,135 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,063,103 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,382,114 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,444,516 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,945,081 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,227,172 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201556417,285$419,010
201668516,188$513,242
201773622,832$659,792
201870563,784$1,347,476
201960595,926$1,955,135
2020565102,919$2,063,103
2021619119,693$2,382,114
2022606115,322$2,444,516
2023633176,388$2,945,081
2024680226,442$3,227,172

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.2M$4.5M2015 Drug cost: $1,018,246 (USD; Tot_Drug_Cst)2016 Drug cost: $1,526,265 (USD; Tot_Drug_Cst)2017 Drug cost: $1,840,467 (USD; Tot_Drug_Cst)2018 Drug cost: $2,296,527 (USD; Tot_Drug_Cst)2019 Drug cost: $2,127,695 (USD; Tot_Drug_Cst)2020 Drug cost: $1,820,959 (USD; Tot_Drug_Cst)2021 Drug cost: $2,201,988 (USD; Tot_Drug_Cst)2022 Drug cost: $2,551,306 (USD; Tot_Drug_Cst)2023 Drug cost: $3,180,683 (USD; Tot_Drug_Cst)2024 Drug cost: $4,463,642 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153341,922$1,018,246
20164142,359$1,526,265
20174872,706$1,840,467
20184472,675$2,296,527
20193822,217$2,127,695
20204142,342$1,820,959
20214322,461$2,201,988
20224192,165$2,551,306
20234512,417$3,180,683
20245112,940$4,463,642

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$7.4K$15K2018 Medicare payment: $1,124 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $910 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $1,373 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $14,857 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $8,868 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $3,108 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $867 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181515$1,124
20191111$910
20201820$1,373
20214765$14,857
20222869$8,868
20231145$3,108
2024N/R14$867

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4971,392$99
80053Blood test, comprehensive group of blood chemicals5471,549$10
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count5411,523$8
86140Measurement c-reactive protein for detection of infection or inflammation4751,412$5
36415Insertion of needle into vein for collection of blood sample5581,606$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab1393,884$1,036,977
Enbrel SureclickEtanercept621,820$480,070
Xeljanz XrTofacitinib Citrate592,070$405,192
Simponi AriaGolimumab341,740$349,917
TremfyaGuselkumab211,148$289,823

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E0745Neuromuscular stimulator, electronic shock unitYN/R14$867

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.51$1,066ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jeffrey Todd Landis, M.D.?

Tedicare shows public-source Medicare data for Jeffrey Todd Landis, M.D. (NPI 1528155439), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey Todd Landis, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jeffrey Todd Landis, M.D.?

Jeffrey Todd Landis, M.D. is linked to NASSERI CLINIC OF ARTHRITIC & RHEUMATIC DISEASES LLC (billing NPI 1821286766) in the available physician profile data.

Does Jeffrey Todd Landis, M.D. have Open Payments data?

Jeffrey Todd Landis, M.D. has 51 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.